Coronary microvascular disease in humans.

Area of Science:

• Cardiology
• Vascular Biology
• Physiology

Background:

• Myocardial perfusion abnormalities can occur without significant epicardial coronary artery disease.
• Conditions like microvascular angina, hypertension, and left ventricular hypertrophy are associated with these abnormalities.
• Endothelial dysfunction is implicated in microvascular dysfunction, but its exact mechanisms remain unclear.

Purpose of the Study:

• To explore the mechanisms underlying myocardial perfusion abnormalities in the absence of epicardial coronary artery disease.
• To investigate the role of endothelial dysfunction and nitric oxide in coronary microvascular derangements.
• To identify potential therapeutic strategies for patients with coronary microvascular dysfunction.

Main Methods:

• Review of existing literature on myocardial perfusion, coronary microcirculation, and endothelial function.
• Analysis of studies investigating cardiovascular disorders associated with microvascular abnormalities.
• Examination of the role of nitric oxide in regulating vascular tone and coronary blood flow.

Main Results:

• Patients exhibit limited coronary microvascular dilator reserve, sometimes with evidence of myocardial ischemia.
• Primary microvascular hyperconstriction (spasm) may cause ischemia in some patients with rest angina.
• Decreased nitric oxide availability is a potential factor in endothelial dysfunction and microvascular derangements.

Conclusions:

• Coronary microvascular dysfunction is a significant contributor to myocardial perfusion abnormalities in various cardiovascular diseases.
• Endothelial dysfunction, potentially involving reduced nitric oxide, plays a key role in these microvascular derangements.
• Targeting nitric oxide pathways presents a promising therapeutic avenue for managing coronary microvascular dysfunction.